Treace Medical Concepts Inc TMCI

NAS: TMCI | ISIN: US89455T1097   18:12
5,000 USD (0,00%)
(0,00%)   18:12
Grafiek Treace Medical Concepts Inc Grafiek Treace Medical Concepts Inc

Treace Medical Concepts Inc in het nieuws

6 mei 2023 · TREACE SHAREHOLDER NOTICE: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Treace To Contact Him Directly To Discuss Their Options · Persbericht

29 april 2023 · TREACE SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Treace To Contact Him Directly To Discuss Their Options · Persbericht

15 april 2023 · TREACE SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Treace To Contact Him Directly To Discuss Their Options · Persbericht

1 april 2023 · TREACE SHAREHOLDER NOTICE: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Treace To Contact Him Directly To Discuss Their Options · Persbericht

11 maart 2023 · TREACE SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Treace To Contact Him Directly To Discuss Their Options · Persbericht

26 januari 2023 · TREACE SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Treace To Contact Him Directly To Discuss Their Options · Persbericht

11 januari 2023 · TREACE SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Treace To Contact Him Directly To Discuss Their Options · Persbericht

4 januari 2023 · TREACE SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Treace To Contact Him Directly To Discuss Their Options · Persbericht

28 december 2022 · TREACE SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Treace To Contact Him Directly To Discuss Their Options · Persbericht

21 december 2022 · Treace Shareholder Action Reminder · Persbericht

Profiel Treace Medical Concepts Inc

Website: treace.com

Hoofdzetel: Ponte Vedra, FL vlag Verenigde Staten

CEO: John T. Treace

Werknemers: 371

Aandelen Treace Medical Concepts Inc

Beurswaarde: 310,04 miljoen USD

Effecten: 62,01 miljoen

Winst per aandeel (12 maand):  PLUS

Beta: 1,77

Mijn selecties